Financial Services

German giant Hapag-Lloyd's $4.2B cash buyout of ZIM creates a new shipping powerhouse and a unique Israeli carrier to secure national interests.

Atlanta's World Neuroscience Day Conference returns to explore the brain-heart connection, demystify clinical trials, and empower a growing community.

A new partnership combines fitness and philanthropy, leveraging a national anti-bullying movement to support youth programs across Canada. Here's how you can join.

For the 13th straight year, LocumTenens.com has won top service awards, setting a gold standard in a healthcare staffing market facing critical shortages.

Direct-to-Film printing is maturing, driven by automation, powderless systems, and advanced color, moving from niche to industrial-scale production.

Manic Panic's new Inter-Gel-Actic collection features a revolutionary gel formula designed to make vibrant, at-home hair color easier than ever before.

With no approved nonsurgical options for plantar fibromatosis, Keenova's new study and late-stage trial offer a significant glimmer of hope for sufferers.

Hidden drafts and duct leaks could be wasting up to 30% of your heat. A local expert reveals how to find and fix them before spring arrives.

Carbon promotes prolific inventor Jason Rolland to CTO, signaling a strategic doubling-down on advanced materials to lead the next era of manufacturing.

As the EV revolution accelerates, thermal management is becoming a critical, high-stakes market, dictating battery life, vehicle range, and safety.

Dr. Batra's launches XODerma, a high-tech exosome skin therapy in Dubai, blending homeopathy with cellular science. But does the hype outpace regulation?

Indian clean energy giant ReNew posts stellar results, slashing losses and boosting profits, thanks to its booming solar manufacturing division.

The global energy giant unveils a new strategic roadmap and lubricants in India, betting on its distributor network to navigate a competitive, evolving market.

A landmark trial for Roche’s Gazyva shows unprecedented success in treating primary membranous nephropathy, offering hope of preventing kidney failure.

Nicox's novel glaucoma drug NCX 470 receives positive FDA feedback, keeping its 2026 U.S. market submission on track to challenge a $7B industry.

A new House Farm Bill threatens to overturn state animal welfare laws, weaken puppy mill protections, and ignore horse slaughter, sparking a major backlash.

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

Panama finalizes its multi-billion dollar bond tender offer, a strategic move to refinance debt amid fiscal pressures and a changing economic landscape.

The junior miner's new Shareholder Rights Plan is a defensive maneuver. Is it a sign of confidence, a hint of vulnerability, or a growing industry trend?

With a new interim CEO and mounting financial pressure, VERSES AI's upcoming investor webinar is a pivotal test of its bio-inspired AI vision.